Topics

Savi Media Group, Inc. Company Profile

02:36 EDT 19th July 2019 | BioPortfolio

SaviCorp is the evolution of more than twenty years of automotive engine emissions testing and materials research and development. The Company was formed to create, support and license a patented supplementary vehicle emissions reduction and fuel efficiency technology to reduce emissions and improve efficiency. Using proprietary methods and processes, SaviCorp's DynoValve (www.dynovalve.com) saves fuel, improves performance and protects the environment, extending engine life, lessoning the carbon footprint, resulting in dramatic savings in both fuel and oil.


News Articles [1207 Associated News Articles listed on BioPortfolio]

TransCanna Looks to Streamline Production & Distribution -- CFN Media

Seattle, Washington--(Newsfile Corp. - May 8, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces the ...

Wildflower Expands Offering, US and European Footprints -- CFN Media

Seattle, Washington--(Newsfile Corp. - May 29, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces the...

FinCanna's QVI Looks to Become California's Premier Contract Manufacturer -- CFN Media

Seattle, Washington--(Newsfile Corp. - June 13, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry announces pub...

FSD Pharma CEO Lays Out Roadmap in Exclusive Interview with CFN Media

Seattle, Washigton--(Newsfile Corp. - May 10, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces publ...

FSD Pharma Doubles Down on Endocannabinoid-based Pain Management -- CFN Media

Seattle, Washington--(Newsfile Corp. - May 1, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces publ...

Halo Labs Improves Transparency with Move to OTCQX -- CFN Media

Seattle, Washington--(Newsfile Corp. - May 8, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces publ...

An Exclusive Interview with Penny Green, CEO of The Yield Growth Corp. -- CFN Media

Seattle, Washington--(Newsfile Corp. - May 8, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces publ...

Cansortium's Canadian Licensing Advances International Expansion -- CFN Media

Seattle, Washington--(Newsfile Corp. - June 11, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces th...

PubMed Articles [2283 Associated PubMed Articles listed on BioPortfolio]

Preliminary investigation of the effects of an FCF inhibitor interference with Septin in the early stage embryos in mice.

The objective of the present study was to investigate the effects of for chlorfenuron (FCF) interference with the septin protein on early stage embryos in mice. The 1‑cell embryos were collected and...

Potent humanin analogue (HNG) protects human sperm from freeze-thaw-induced damage.

This study was aimed to investigate the protective effect of potent humanin analogue (HNG) supplementation to freezing media on freezing-thawing induced human sperm damage. We collected semen samples ...

Predicting attention shifting abilities from self-reported media multitasking.

Media multitasking is an increasingly prominent behavior in affluent societies. However, it still needs to be established if simultaneous use of several modes of media content has an influence on high...

Predictors of Social Media Self-Control Failure: Immediate Gratifications, Habitual Checking, Ubiquity, and Notifications.

Social media users often experience the difficulty of controlling their social media use while having important tasks to do. Recent theorizing on self-control and media use proposes four possible fact...

Contrast media (meglumine diatrizoate) aggravates renal inflammation, oxidative DNA damage and apoptosis in diabetic rats which is restored by sulforaphane through Nrf2/HO-1 reactivation.

Diabetes mellitus is an independent risk factor for renal impairment in patients exposed to contrast media. It doubles the risk and decreases survival rate of contrast induced nephropathy (CIN). Sulfo...

Clinical Trials [5220 Associated Clinical Trials listed on BioPortfolio]

ACURATE TA™ Valve Implantation: SAVI Registry (Surveillance Plan #2011-02) (TA-SAVI)

Post-market registry on ACURATE TA™ Transapical Aortic Bioprosthesis and ACURATE TA™ Delivery System implantation in patients presenting severe symptomatic aortic stenosis to provide s...

Testing a Community Intervention to Increase Aspirin Use

This research will test the effect of mass media or mass media plus a clinic based education program will improve appropriate aspirin use for cardiovascular disease prevention. It is a gro...

Evaluation of Longer Duration Use of the SAVI SCOUT Surgical Guidance System for Excision of Breast and Axillary Lesions in Neo-adjuvant Therapy Patients: A Pilot Study

The purpose of this study is to evaluate the performance of FDA cleared SAVI SCOUT Breast Localization and Surgical Guidance System (SCOUT) over a longer duration prior to surgery. The dev...

Youth Health and Social Media

The purpose of this study is test the American Academy of Pediatrics (AAP) Family Media Use plan among teens and their parents through a randomized intervention and assess impact on outcom...

Sequential vs. Monophasic Media Impact Trial (SuMMIT)

To evaluate the impact of two FDA approved culture media on potential of human embryos resulting from IVF (sequential & monophasic media). Half of each patient's embryos will be randomly ...

Companies [2575 Associated Companies listed on BioPortfolio]

Savi Media Group, Inc.

SaviCorp is the evolution of more than twenty years of automotive engine emissions testing and materials research and development. The Company was formed to create, support and license a patented supp...

Cianna Medical, Inc.

Cianna Medical, Inc. is a medical device company focused on women's health and dedicated to the innovative treatment of early-stage breast cancer. The company manufactures and mar...

La VOX Media Group

Saludify is part of the La VOX Media Group that owns VOXXI, the premier independent platform for Hispanic news, analysis and commentary that was launched last year to fill the Lat...

W2 Group, Inc.

W2 Group is a global marketing services ecosystem that helps CMOs in their new role as builders of communities and content aggregators. W2 Group companies, including Digital ...

Savi Technology - Lockheed Martin

More Information about "Savi Media Group, Inc." on BioPortfolio

We have published hundreds of Savi Media Group, Inc. news stories on BioPortfolio along with dozens of Savi Media Group, Inc. Clinical Trials and PubMed Articles about Savi Media Group, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Savi Media Group, Inc. Companies in our database. You can also find out about relevant Savi Media Group, Inc. Drugs and Medications on this site too.

Quick Search

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record